—
Price
—
Market Cap
—
P/E Ratio
—
Forward P/E
—
EPS (TTM)
—
Dividend Yield
—
Cash
—
Total Debt
—
Shares Out
Institutional Ownership of Ziopharm Oncology Inc
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for Ziopharm Oncology Inc
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2021-Q3 | |||||
| SELL | EXIT | — | — | — | |
| 2021-Q2 | |||||
| SELL | -12.8% | 10.3M | $27M | — | |
| 2021-Q1 | |||||
| SELL | -5.1% | 11.8M | $43M | — | |
| 2020-Q4 | |||||
| BUY | +0.7% | 12.5M | $31M | — | |
| 2020-Q3 | |||||
| SELL | -1.9% | 12.4M | $31M | — | |
| 2020-Q2 | |||||
| SELL | -1.9% | 12.6M | $41M | — | |
| 2020-Q1 | |||||
| BUY | +1.0% | 12.9M | $32M | — | |
| 2019-Q4 | |||||
| SELL | -1.9% | 12.7M | $60M | — | |
| 2019-Q3 | |||||
| BUY | +40.5% | 13.0M | $56M | — | |
| 2019-Q1 | |||||
| SELL | -0.3% | 9.2M | $36M | — | |
| 2018-Q4 | |||||
| BUY | +92.3% | 9.3M | $17M | — | |
| 2018-Q3 | |||||
| SELL | -2.0% | 4.8M | $15M | — | |
| 2018-Q2 | |||||
| SELL | -2.4% | 4.9M | $15M | — | |
| 2018-Q1 | |||||
| SELL | -0.9% | 5.0M | $20M | — | |
Insider Trading for Ziopharm Oncology Inc
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.